APO Research
Talk to an analyst

APO RESEARCH · REPORT

Heparin

Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machine. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium. This report is revolving around Heparin Active Pharmaceutical Ingredients (API).

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machine. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium. This report is revolving around Heparin Active Pharmaceutical Ingredients (API).

Selected research

Industry Growth & Trends

Global Heparin Industry Growth and Trends Forecast to 2032

8 January 2026101 pages

Choose your research edition.

Industry ResearchHeparin Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Heparin Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Heparin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Heparin Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Heparin Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machine. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium. This report is revolving around Heparin Active Pharmaceutical Ingredients (API).

Global Heparin key players include Hepalink, Bioibérica, Pfizer, King-friend Biochemical Pharmaceutical, Jiulong Biochemicals, etc. Global top five manufacturers hold a share about 55%. Europe is the largest market, with a share about 40%, followed by USA, with a share about 35 percent. In terms of product, Heparin Sodium Raw Material Drug is the largest segment, with a share about 96%. And in terms of application, the largest application is Low Molecular Weight Heparin Preparation, followed by Standard Heparin Preparation.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Heparin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Heparin market size, estimates, and forecasts are presented in terms of sales volume (B Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Heparin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Heparin.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Heparin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Heparin Market by Company

Hepalink

Changshan Pharm

Qianhong Bio-pharma

Opocrin

Pfizer

Aspen Oss

King-friend Biochemical Pharmaceutical

Bioibérica

Dongcheng Biochemicals

Jiulong Biochemicals

Tiandong

Xinbai

Yino Pharma

Deebio

Heparin Segment by Type

Heparin Sodium Raw Material Drug

Heparin Calcium Raw Material Drug

Heparin Segment by Application

Low Molecular Weight Heparin Preparation

Standard Heparin Preparation

Heparin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Heparin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Heparin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Heparin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Heparin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Heparin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Heparin Sodium Raw Material Drug Table 2. Major Company of Heparin Calcium Raw Material Drug Table 3. Global Heparin Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Heparin Sales by Type (2021-2026) & (B Units) Table 5. Global Heparin Sales Market Share in Volume by Type (2021-2026) Table 6. Global Heparin Sales by Type (2021-2026) & (US$ Million) Table 7. Global Heparin Sales Market Share in Value by Type (2021-2026) Table 8. Global Heparin Price by Type (2021-2026) & (USD/Unit) Table 9. Global Heparin Sales by Type (2027-2032) & (B Units) Table 10. Global Heparin Sales Market Share in Volume by Type (2027-2032) Table 11. Global Heparin Sales by Type (2027-2032) & (US$ Million) Table 12. Global Heparin Sales Market Share in Value by Type (2027-2032) Table 13. Global Heparin Price by Type (2027-2032) & (USD/Unit) Table 14. North America Heparin Sales by Type (2021-2026) & (B Units) Table 15. North America Heparin Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Heparin Sales by Type (2021-2026) & (B Units) Table 17. Europe Heparin Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Heparin Sales by Type (2021-2026) & (B Units) Table 19. Asia-Pacific Heparin Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Heparin Sales by Type (2021-2026) & (B Units) Table 21. Latin America Heparin Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Heparin Sales by Type (2021-2026) & (B Units) Table 23. Middle East and Africa Heparin Sales by Type (2021-2026) & (US$ Million) Table 24. Heparin Industry Trends Table 25. Heparin Industry Drivers Table 26. Heparin Industry Opportunities and Challenges Table 27. Heparin Industry Restraints Table 28. Global Heparin Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Heparin Revenue Market Share by Company (2021-2026) Table 30. Global Heparin Sales by Company (2021-2026) & (B Units) Table 31. Global Heparin Sales Share by Company (2021-2026) Table 32. Global Heparin Market Price by Company (2021-2026) & (USD/Unit) Table 33. Global Heparin Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Heparin Major Company Production Sites and Headquarters Table 35. Global Heparin Company, Product Type & Application Table 36. Global Heparin Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Heparin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Heparin Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Heparin Sales by Region (2021-2026) & (B Units) Table 41. Global Heparin Sales Market Share in Volume by Region (2021-2026) Table 42. Global Heparin Sales by Region (2021-2026) & (US$ Million) Table 43. Global Heparin Sales Market Share in Value by Region (2021-2026) Table 44. Global Heparin Sales (B Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 45. Global Heparin Sales by Region (2027-2032) & (B Units) Table 46. Global Heparin Sales Market Share in Volume by Region (2027-2032) Table 47. Global Heparin Sales by Region (2027-2032) & (US$ Million) Table 48. Global Heparin Sales Market Share in Value by Region (2027-2032) Table 49. Global Heparin Sales (B Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2027-2032) Table 50. Global Heparin Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Heparin Sales by Application (2021-2026) & (B Units) Table 52. Global Heparin Sales Market Share in Volume by Application (2021-2026) Table 53. Global Heparin Sales by Application (2021-2026) & (US$ Million) Table 54. Global Heparin Sales Market Share in Value by Application (2021-2026) Table 55. Global Heparin Price by Application (2021-2026) & (USD/Unit) Table 56. Global Heparin Sales by Application (2027-2032) & (B Units) Table 57. Global Heparin Sales Market Share in Volume by Application (2027-2032) Table 58. Global Heparin Sales by Application (2027-2032) & (US$ Million) Table 59. Global Heparin Sales Market Share in Value by Application (2027-2032) Table 60. Global Heparin Price by Application (2027-2032) & (USD/Unit) Table 61. North America Heparin Sales by Application (2021-2026) & (B Units) Table 62. North America Heparin Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Heparin Sales by Application (2021-2026) & (B Units) Table 64. Europe Heparin Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Heparin Sales by Application (2021-2026) & (B Units) Table 66. Asia-Pacific Heparin Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Heparin Sales by Application (2021-2026) & (B Units) Table 68. Latin America Heparin Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Heparin Sales by Application (2021-2026) & (B Units) Table 70. Middle East and Africa Heparin Sales by Application (2021-2026) & (US$ Million) Table 71. Hepalink Company Information Table 72. Hepalink Business Overview Table 73. Hepalink Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 74. Hepalink Heparin Product Portfolio Table 75. Hepalink Recent Development Table 76. Changshan Pharm Company Information Table 77. Changshan Pharm Business Overview Table 78. Changshan Pharm Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 79. Changshan Pharm Heparin Product Portfolio Table 80. Changshan Pharm Recent Development Table 81. Qianhong Bio-pharma Company Information Table 82. Qianhong Bio-pharma Business Overview Table 83. Qianhong Bio-pharma Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 84. Qianhong Bio-pharma Heparin Product Portfolio Table 85. Qianhong Bio-pharma Recent Development Table 86. Opocrin Company Information Table 87. Opocrin Business Overview Table 88. Opocrin Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 89. Opocrin Heparin Product Portfolio Table 90. Opocrin Recent Development Table 91. Pfizer Company Information Table 92. Pfizer Business Overview Table 93. Pfizer Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 94. Pfizer Heparin Product Portfolio Table 95. Pfizer Recent Development Table 96. Aspen Oss Company Information Table 97. Aspen Oss Business Overview Table 98. Aspen Oss Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 99. Aspen Oss Heparin Product Portfolio Table 100. Aspen Oss Recent Development Table 101. King-friend Biochemical Pharmaceutical Company Information Table 102. King-friend Biochemical Pharmaceutical Business Overview Table 103. King-friend Biochemical Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 104. King-friend Biochemical Pharmaceutical Heparin Product Portfolio Table 105. King-friend Biochemical Pharmaceutical Recent Development Table 106. Bioibérica Company Information Table 107. Bioibérica Business Overview Table 108. Bioibérica Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 109. Bioibérica Heparin Product Portfolio Table 110. Bioibérica Recent Development Table 111. Dongcheng Biochemicals Company Information Table 112. Dongcheng Biochemicals Business Overview Table 113. Dongcheng Biochemicals Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 114. Dongcheng Biochemicals Heparin Product Portfolio Table 115. Dongcheng Biochemicals Recent Development Table 116. Jiulong Biochemicals Company Information Table 117. Jiulong Biochemicals Business Overview Table 118. Jiulong Biochemicals Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 119. Jiulong Biochemicals Heparin Product Portfolio Table 120. Jiulong Biochemicals Recent Development Table 121. Tiandong Company Information Table 122. Tiandong Business Overview Table 123. Tiandong Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 124. Tiandong Heparin Product Portfolio Table 125. Tiandong Recent Development Table 126. Xinbai Company Information Table 127. Xinbai Business Overview Table 128. Xinbai Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 129. Xinbai Heparin Product Portfolio Table 130. Xinbai Recent Development Table 131. Yino Pharma Company Information Table 132. Yino Pharma Business Overview Table 133. Yino Pharma Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 134. Yino Pharma Heparin Product Portfolio Table 135. Yino Pharma Recent Development Table 136. Deebio Company Information Table 137. Deebio Business Overview Table 138. Deebio Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 139. Deebio Heparin Product Portfolio Table 140. Deebio Recent Development Table 141. North America Heparin Market Size Growth Rate (CAGR) by Country (B Units): 2021 VS 2025 VS 2032 Table 142. North America Heparin Sales by Country (2021-2026) & (B Units) Table 143. North America Heparin Sales Market Share by Country (2021-2026) Table 144. North America Heparin Sales Forecast by Country (2027-2032) & (B Units) Table 145. North America Heparin Sales Market Share Forecast by Country (2027-2032) Table 146. North America Heparin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. North America Heparin Market Size by Country (2021-2026) & (US$ Million) Table 148. North America Heparin Market Share by Country (2021-2026) Table 149. North America Heparin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. North America Heparin Market Share Forecast by Country (2027-2032) Table 151. Europe Heparin Market Size Growth Rate (CAGR) by Country (B Units): 2021 VS 2025 VS 2032 Table 152. Europe Heparin Sales by Country (2021-2026) & (B Units) Table 153. Europe Heparin Sales Market Share by Country (2021-2026) Table 154. Europe Heparin Sales Forecast by Country (2027-2032) & (B Units) Table 155. Europe Heparin Sales Market Share Forecast by Country (2027-2032) Table 156. Europe Heparin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Europe Heparin Market Size by Country (2021-2026) & (US$ Million) Table 158. Europe Heparin Market Share by Country (2021-2026) Table 159. Europe Heparin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Europe Heparin Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Heparin Market Size Growth Rate (CAGR) by Country (B Units): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Heparin Sales by Country (2021-2026) & (B Units) Table 163. Asia-Pacific Heparin Sales Market Share by Country (2021-2026) Table 164. Asia-Pacific Heparin Sales Forecast by Country (2027-2032) & (B Units) Table 165. Asia-Pacific Heparin Sales Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific Heparin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific Heparin Market Size by Country (2021-2026) & (US$ Million) Table 168. Asia-Pacific Heparin Market Share by Country (2021-2026) Table 169. Asia-Pacific Heparin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Asia-Pacific Heparin Market Share Forecast by Country (2027-2032) Table 171. Latin America Heparin Market Size Growth Rate (CAGR) by Country (B Units): 2021 VS 2025 VS 2032 Table 172. Latin America Heparin Sales by Country (2021-2026) & (B Units) Table 173. Latin America Heparin Sales Market Share by Country (2021-2026) Table 174. Latin America Heparin Sales Forecast by Country (2027-2032) & (B Units) Table 175. Latin America Heparin Sales Market Share Forecast by Country (2027-2032) Table 176. Latin America Heparin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Latin America Heparin Market Size by Country (2021-2026) & (US$ Million) Table 178. Latin America Heparin Market Share by Country (2021-2026) Table 179. Latin America Heparin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Latin America Heparin Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Heparin Market Size Growth Rate (CAGR) by Country (B Units): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Heparin Sales by Country (2021-2026) & (B Units) Table 183. Middle East and Africa Heparin Sales Market Share by Country (2021-2026) Table 184. Middle East and Africa Heparin Sales Forecast by Country (2027-2032) & (B Units) Table 185. Middle East and Africa Heparin Sales Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa Heparin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa Heparin Market Size by Country (2021-2026) & (US$ Million) Table 188. Middle East and Africa Heparin Market Share by Country (2021-2026) Table 189. Middle East and Africa Heparin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Middle East and Africa Heparin Market Share Forecast by Country (2027-2032) Table 191. Key Raw Materials Table 192. Raw Materials Key Suppliers Table 193. Heparin Distributors List Table 194. Heparin Customers List Table 195. Research Programs/Design for This Report Table 196. Authors List of This Report Table 197. Secondary Sources Table 198. Primary Sources List of Figures Figure 1. Heparin Image Figure 2. Global Heparin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Heparin Market Size (2021-2032) & (US$ Million) Figure 4. Global Heparin Sales (2021-2032) & (B Units) Figure 5. Heparin Sodium Raw Material Drug Image Figure 6. Global Heparin Sodium Raw Material Drug Sales YoY Growth (2021-2032) & (B Units) Figure 7. Heparin Calcium Raw Material Drug Image Figure 8. Global Heparin Calcium Raw Material Drug Sales YoY Growth (2021-2032) & (B Units) Figure 9. Global Heparin Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Heparin Market Share by Type 2025 VS 2032 Figure 11. North America Heparin Sales Market Share in Volume by Type in 2025 Figure 12. North America Heparin Sales Market Share in Value by Type in 2025 Figure 13. Europe Heparin Sales Market Share in Volume by Type in 2025 Figure 14. Europe Heparin Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Heparin Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Heparin Sales Market Share in Value by Type in 2025 Figure 17. Latin America Heparin Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Heparin Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Heparin Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Heparin Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Heparin Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Low Molecular Weight Heparin Preparation Image Figure 24. Global Low Molecular Weight Heparin Preparation Sales YoY Growth (2021-2032) & (B Units) Figure 25. Standard Heparin Preparation Image Figure 26. Global Standard Heparin Preparation Sales YoY Growth (2021-2032) & (B Units) Figure 27. Global Heparin Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Heparin Market Share by Application 2025 VS 2032 Figure 29. North America Heparin Sales Market Share in Volume by Application in 2025 Figure 30. North America Heparin Sales Market Share in Value by Application in 2025 Figure 31. Europe Heparin Sales Market Share in Volume by Application in 2025 Figure 32. Europe Heparin Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Heparin Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Heparin Sales Market Share in Value by Application in 2025 Figure 35. Latin America Heparin Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Heparin Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Heparin Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Heparin Sales Market Share in Value by Application in 2025 Figure 39. North America Heparin Sales by Country: 2021 VS 2025 VS 2032 (B Units) Figure 40. North America Heparin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Heparin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Heparin Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Heparin Sales by Country: 2021 VS 2025 VS 2032 (B Units) Figure 44. Europe Heparin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Heparin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Heparin Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Heparin Sales by Country: 2021 VS 2025 VS 2032 (B Units) Figure 48. Asia-Pacific Heparin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Heparin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Heparin Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Heparin Sales by Country: 2021 VS 2025 VS 2032 (B Units) Figure 52. Latin America Heparin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Heparin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Heparin Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Heparin Sales by Country: 2021 VS 2025 VS 2032 (B Units) Figure 56. Middle East and Africa Heparin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Heparin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Heparin Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Heparin Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Heparin Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Heparin Sodium Raw Material Drug
  • Heparin Calcium Raw Material Drug
Applications
  • Low Molecular Weight Heparin Preparation
  • Standard Heparin Preparation
Companies covered
  • Hepalink
  • Changshan Pharm
  • Qianhong Bio-pharma
  • Opocrin
  • Pfizer
  • Aspen Oss
  • King-friend Biochemical Pharmaceutical
  • Bioibérica
  • Dongcheng Biochemicals
  • Jiulong Biochemicals
  • Tiandong
  • Xinbai
  • Yino Pharma
  • Deebio

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Heparin Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Heparin Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Heparin Market by Type
  6. 1.3.1 Heparin Sodium Raw Material Drug
  7. 1.3.2 Heparin Calcium Raw Material Drug
  8. 1.4 Global Heparin Market Size by Type
  9. 1.4.1 Global Heparin Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Heparin Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Heparin Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Heparin Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Heparin Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Heparin Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Heparin Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Heparin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Heparin Industry Trends
  2. 2.2 Heparin Industry Drivers
  3. 2.3 Heparin Industry Opportunities and Challenges
  4. 2.4 Heparin Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Heparin Revenue (2021-2026)
  2. 3.2 Global Top Players by Heparin Sales (2021-2026)
  3. 3.3 Global Top Players by Heparin Price (2021-2026)
  4. 3.4 Global Heparin Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Heparin Major Company Production Sites & Headquarters
  6. 3.6 Global Heparin Company, Product Type & Application
  7. 3.7 Global Heparin Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Heparin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Heparin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Heparin Tier 1, Tier 2, and Tier 3
4 Heparin Regional Status and Outlook
  1. 4.1 Global Heparin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Heparin Historic Market Size by Region
  3. 4.2.1 Global Heparin Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Heparin Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Heparin Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Heparin Forecasted Market Size by Region
  7. 4.3.1 Global Heparin Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Heparin Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Heparin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Heparin by Application
  1. 5.1 Heparin Market by Application
  2. 5.1.1 Low Molecular Weight Heparin Preparation
  3. 5.1.2 Standard Heparin Preparation
  4. 5.2 Global Heparin Market Size by Application
  5. 5.2.1 Global Heparin Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Heparin Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Heparin Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Heparin Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Heparin Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Heparin Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Heparin Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Heparin Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Hepalink
  2. 6.1.1 Hepalink Company Information
  3. 6.1.2 Hepalink Business Overview
  4. 6.1.3 Hepalink Heparin Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Hepalink Heparin Product Portfolio
  6. 6.1.5 Hepalink Recent Developments
  7. 6.2 Changshan Pharm
  8. 6.2.1 Changshan Pharm Company Information
  9. 6.2.2 Changshan Pharm Business Overview
  10. 6.2.3 Changshan Pharm Heparin Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Changshan Pharm Heparin Product Portfolio
  12. 6.2.5 Changshan Pharm Recent Developments
  13. 6.3 Qianhong Bio-pharma
  14. 6.3.1 Qianhong Bio-pharma Company Information
  15. 6.3.2 Qianhong Bio-pharma Business Overview
  16. 6.3.3 Qianhong Bio-pharma Heparin Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Qianhong Bio-pharma Heparin Product Portfolio
  18. 6.3.5 Qianhong Bio-pharma Recent Developments
  19. 6.4 Opocrin
  20. 6.4.1 Opocrin Company Information
  21. 6.4.2 Opocrin Business Overview
  22. 6.4.3 Opocrin Heparin Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Opocrin Heparin Product Portfolio
  24. 6.4.5 Opocrin Recent Developments
  25. 6.5 Pfizer
  26. 6.5.1 Pfizer Company Information
  27. 6.5.2 Pfizer Business Overview
  28. 6.5.3 Pfizer Heparin Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Pfizer Heparin Product Portfolio
  30. 6.5.5 Pfizer Recent Developments
  31. 6.6 Aspen Oss
  32. 6.6.1 Aspen Oss Company Information
  33. 6.6.2 Aspen Oss Business Overview
  34. 6.6.3 Aspen Oss Heparin Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Aspen Oss Heparin Product Portfolio
  36. 6.6.5 Aspen Oss Recent Developments
  37. 6.7 King-friend Biochemical Pharmaceutical
  38. 6.7.1 King-friend Biochemical Pharmaceutical Company Information
  39. 6.7.2 King-friend Biochemical Pharmaceutical Business Overview
  40. 6.7.3 King-friend Biochemical Pharmaceutical Heparin Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 King-friend Biochemical Pharmaceutical Heparin Product Portfolio
  42. 6.7.5 King-friend Biochemical Pharmaceutical Recent Developments
  43. 6.8 Bioibérica
  44. 6.8.1 Bioibérica Company Information
  45. 6.8.2 Bioibérica Business Overview
  46. 6.8.3 Bioibérica Heparin Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Bioibérica Heparin Product Portfolio
  48. 6.8.5 Bioibérica Recent Developments
  49. 6.9 Dongcheng Biochemicals
  50. 6.9.1 Dongcheng Biochemicals Company Information
  51. 6.9.2 Dongcheng Biochemicals Business Overview
  52. 6.9.3 Dongcheng Biochemicals Heparin Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Dongcheng Biochemicals Heparin Product Portfolio
  54. 6.9.5 Dongcheng Biochemicals Recent Developments
  55. 6.10 Jiulong Biochemicals
  56. 6.10.1 Jiulong Biochemicals Company Information
  57. 6.10.2 Jiulong Biochemicals Business Overview
  58. 6.10.3 Jiulong Biochemicals Heparin Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Jiulong Biochemicals Heparin Product Portfolio
  60. 6.10.5 Jiulong Biochemicals Recent Developments
  61. 6.11 Tiandong
  62. 6.11.1 Tiandong Company Information
  63. 6.11.2 Tiandong Business Overview
  64. 6.11.3 Tiandong Heparin Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Tiandong Heparin Product Portfolio
  66. 6.11.5 Tiandong Recent Developments
  67. 6.12 Xinbai
  68. 6.12.1 Xinbai Company Information
  69. 6.12.2 Xinbai Business Overview
  70. 6.12.3 Xinbai Heparin Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Xinbai Heparin Product Portfolio
  72. 6.12.5 Xinbai Recent Developments
  73. 6.13 Yino Pharma
  74. 6.13.1 Yino Pharma Company Information
  75. 6.13.2 Yino Pharma Business Overview
  76. 6.13.3 Yino Pharma Heparin Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Yino Pharma Heparin Product Portfolio
  78. 6.13.5 Yino Pharma Recent Developments
  79. 6.14 Deebio
  80. 6.14.1 Deebio Company Information
  81. 6.14.2 Deebio Business Overview
  82. 6.14.3 Deebio Heparin Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Deebio Heparin Product Portfolio
  84. 6.14.5 Deebio Recent Developments
7 North America by Country
  1. 7.1 North America Heparin Sales by Country
  2. 7.1.1 North America Heparin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Heparin Sales by Country (2021-2026)
  4. 7.1.3 North America Heparin Sales Forecast by Country (2027-2032)
  5. 7.2 North America Heparin Market Size by Country
  6. 7.2.1 North America Heparin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Heparin Market Size by Country (2021-2026)
  8. 7.2.3 North America Heparin Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Heparin Sales by Country
  2. 8.1.1 Europe Heparin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Heparin Sales by Country (2021-2026)
  4. 8.1.3 Europe Heparin Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Heparin Market Size by Country
  6. 8.2.1 Europe Heparin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Heparin Market Size by Country (2021-2026)
  8. 8.2.3 Europe Heparin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Heparin Sales by Country
  2. 9.1.1 Asia-Pacific Heparin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Heparin Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Heparin Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Heparin Market Size by Country
  6. 9.2.1 Asia-Pacific Heparin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Heparin Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Heparin Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Heparin Sales by Country
  2. 10.1.1 South America Heparin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Heparin Sales by Country (2021-2026)
  4. 10.1.3 South America Heparin Sales Forecast by Country (2027-2032)
  5. 10.2 South America Heparin Market Size by Country
  6. 10.2.1 South America Heparin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Heparin Market Size by Country (2021-2026)
  8. 10.2.3 South America Heparin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Heparin Sales by Country
  2. 11.1.1 Middle East and Africa Heparin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Heparin Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Heparin Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Heparin Market Size by Country
  6. 11.2.1 Middle East and Africa Heparin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Heparin Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Heparin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Heparin Value Chain Analysis
  2. 12.1.1 Heparin Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Heparin Production Mode & Process
  7. 12.2 Heparin Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Heparin Distributors
  10. 12.2.3 Heparin Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst